HIGHLIGHTS
- who: Xiaomei Zhou et al. from the University at Buffalo, United States have published the article: Overexpression of HMGB3 and its prognostic value in breast cancer, in the Journal: (JOURNAL)
- what: Evaluating the predictive value of HMGB3 expression in breast cancer is the goal of this investigation. The authors examined the possible mechanisms through which HMGB3 promotes BRCA and the potential utility of HMGB3 as a predictive biomarker.
- how: The authors used normal tissues from the GTEx dataset as controls to compare HMGB3 expression in tumor and normal BRCA tissues. The results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.